Click for our Prostate Cancer Website En Espanol
Contact & Location

CyberKnife Center of Miami Blog

A Helpful Resource for Our Patients rss

CyberKnife Miami Offers Radiosurgery for Painful Nerve Disorder

by Bevon Findley (SU)

CyberKnife Miami offers stereotactic radiosurgery for the treatment of trigeminal neuralgia, a debilitating nerve disorder characterized by excruciating facial pain.

New Data Validates CyberKnife SBRT for Prostate Cancer Treatment

by Bevon Findley (SU)

Accuray Incorporated announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT).

The study followed 304 patients for a median of 5 years, and many to 6 years post-treatment and found that 97 percent of patients with low-risk and 90.7% of patients with intermediate-risk prostate cancer remained cancer-free throughout that time.

Women Have A New Weapon To Fight Recurring Ovarian & Other Gynecologic Cancers

by Bevon Findley (SU)

The Results of a New Phase ll Study Proves CyberKnife Radio-surgery Is Extremely Effective and Potentially Life-Saving

Lenore’s Story: “Surviving Ovarian Cancer Too Many Times to Count.”

Why More Men Are Choosing CyberKnife To Treat Prostate Cancer

by Bevon Findley (SU)
A new study published in the Wall Street Journal provides more proof as to why mens treatment of choice for prostate cancer should be CyberKnife Radio Surgery. CyberKnife Miami was a big part of the study.

Tumor Patients Have More Treatment Options Then Ever Before!

by Bevon Findley (SU)
Help us spread the word about CyberKnife Miami. Too many people still have no idea how this radio-surgery technology is saving the lives of patients with cancerous and non-cancerous tumors. Tell everyone you know. It could make a major difference in the outcome of their treatment or a loved one’s. Click on the link below and see how and why CyberKnife is giving patients more treatment options.